Viking Therapeutics
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
9920 Pacific Heights Blvd Ste 500, San D...Phone Number
(858) 704-4660Website
www.vikingtherapeutics.comRevenue
$124.7 MillionStock Symbol
VKTXIndustry
ZI Rank: 2
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
4
3
1
1
1
2
About Viking Therapeutics
Viking Therapeutics, founded in 2012, is a clinical-stage biopharmaceutical company focused on developing novel, orally available therapies for metabolic and endocrine disorders. The company specializes in research and development of innovative therapeutics targeting metabolism to improve patient outcomes. Viking Therapeutics has multiple clinical programs in its portfolio, including treatments for lipid and metabolic disorders, X-linked adrenoleukodystrophy, and solutions for patients recovering from hip fractures. The company also has earlier-stage programs targeting metabolic diseases and anemia. Viking Therapeutics holds exclusive worldwide rights to a portfolio of therapeutic programs based on small molecules licensed from other pharmaceutical companies. The company is publicly traded and maintains operations across multiple locations in North America.Explore more
Viking Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Viking Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Viking Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Viking Therapeutics
Check out if Viking Therapeutics is spiking on competitors!
Check if Viking Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Viking Therapeutics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Viking Therapeutics launches new products
Funding: Get notified immidiatlly once Viking Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Viking Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Viking Therapeutics
Compare insights from companies similar to Viking Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Viking Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Viking Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Viking Therapeutics.
Viking Therapeutics financials insights
Gather financial insights about Viking Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2015
Stock Offering
$24M
Viking Therapeutics Tech Stack
A closer look at the technologies used by Viking Therapeutics
Most Recent Scoops
Earnings
Earnings, Finance
Earnings
Earnings, Finance
Earnings
Earnings, Finance
Person-Based
Product Launch
Person-Based
Medical Research, Pharmaceuticals
Viking Therapeutics News & Media
Viking Therapeutics Declined in July, and why its Long-Term Prospects are Undiminished
In a slow news month for the company, investors focused on the cost of its phase 3 trials rather than their benefits.Vertex Just Paid $10 Billion for Crinetics. Here's Why Viking Therapeutics Could Be the Next Big Pharma Takeover Target
There are other reasons to pay attention to Viking Therapeutics.Viking Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Conference call scheduled for 4:30 p.m. ET today -- Phase 3 VANQUISH 1 & 2 Trials for Subcutaneous VK2735 in Obesity Fully Enrolled and Advancing -- -- Oral Phase 3 VK2735 Trial Initiation Expected 4Q26 -- -- VK2735 Maintenance Dosing Data Expected 3Q26 -- -- Phase 1 Study of Amylin...Wall Street Says Buy the Dip in Viking Therapeutics. Here's the Bull Case
The stock looks like a high-risk, high-reward play.
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding Viking Therapeutics
Sign Up For FreeTo access detailed company insights
Viking Therapeutics, founded in 2012, is a clinical-stage biopharmaceutical company focused on developing novel, orally available therapies for metabolic and endocrine disorders. The company specializes in research and development of innovative therapeutics targeting metabolism to improve patient outcomes. Viking Therapeutics has multiple clinical... Read More
